Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · IEX Real-Time Price · USD
15.27
-0.34 (-2.18%)
May 17, 2024, 4:00 PM EDT - Market closed
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $921.17 million as of May 17, 2024. Its market cap has decreased by -31.28% in one year.
Market Cap
921.17M
Enterprise Value
491.96M
1-Year Change
-31.28%
Ranking
Category
Stock Price
$15.27
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has increased from $729.40M to $921.17M, an increase of 26.29%. That is a compound annual growth rate of 6.08%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 921.20M | -2.18% |
May 16, 2024 | 941.70M | 1.63% |
May 15, 2024 | 926.60M | 8.63% |
May 14, 2024 | 853.00M | 3.43% |
May 13, 2024 | 824.70M | -1.01% |
May 10, 2024 | 833.10M | - |
May 9, 2024 | 833.10M | 2.98% |
May 8, 2024 | 809.00M | -2.75% |
May 7, 2024 | 831.90M | - |
May 6, 2024 | 831.90M | -1.21% |
May 3, 2024 | 842.10M | 5.50% |
May 2, 2024 | 798.20M | 4.67% |
May 1, 2024 | 762.60M | 7.11% |
Apr 30, 2024 | 712.00M | -2.24% |
Apr 29, 2024 | 728.30M | 2.38% |
Apr 26, 2024 | 711.40M | -0.59% |
Apr 25, 2024 | 715.60M | -0.17% |
Apr 24, 2024 | 716.80M | -4.96% |
Apr 23, 2024 | 754.20M | -0.63% |
Apr 22, 2024 | 759.00M | 0.64% |
Apr 19, 2024 | 754.20M | 2.71% |
Apr 18, 2024 | 734.30M | -5.21% |
Apr 17, 2024 | 774.70M | -3.02% |
Apr 16, 2024 | 798.80M | -2.13% |
Apr 15, 2024 | 816.20M | -4.25% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Liquidia | 970.06M |
Ocular Therapeutix | 959.54M |
Tyra Biosciences | 958.71M |
Avanos Medical | 935.52M |
ProKidney | 933.93M |
OPKO Health | 917.24M |
Bicycle Therapeutics | 915.75M |
Centessa Pharmaceuticals | 889.27M |